Related references
Note: Only part of the references are listed.The Radiosensitizing Effect of Olanzapine as an Antipsychotic Medication on Glioblastoma Cell
Seyedeh Zahra Allahgholipour et al.
CURRENT RADIOPHARMACEUTICALS (2022)
Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells
Sandipan Datta et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Modulation of Nogo receptor I expression orchestrates myelin-associated infiltration of glioblastoma
Jun-Hee Hong et al.
BRAIN (2021)
Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance
Manendra Singh Tomar et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
Calmodulin/CaMKII-γ mediates prosurvival capability in apicidin-persistent hepatocellular carcinoma cells via ERK1/2/CREB/c-fos signaling pathway
Wei-Chung Hsu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2021)
Chlorpromazine induces cytotoxic autophagy in glioblastoma cells via endoplasmic reticulum stress and unfolded protein response
Silvia Matteoni et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Anticancer Properties of the Antipsychotic Drug Chlorpromazine and Its Synergism With Temozolomide in Restraining Human Glioblastoma Proliferation In Vitro
Silvia Matteoni et al.
FRONTIERS IN ONCOLOGY (2021)
Valproic Acid Enhanced Temozolomide-Induced Anticancer Activity in Human Glioma Through the p53-PUMA Apoptosis Pathway
Hong-Chieh Tsai et al.
FRONTIERS IN ONCOLOGY (2021)
Imipramine impedes glioma progression by inhibiting YAP as a Hippo pathway independent manner and synergizes with temozolomide
Yan Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
The Dopamine D2 Receptor Contributes to the Spheroid Formation Behavior of U87 Glioblastoma Cells
Jillian S. Weissenrieder et al.
PHARMACOLOGY (2020)
Interaction between IDH1 WT and calmodulin and its implications for glioblastoma cell growth and migration
Sunmi Kang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Nausea and Vomiting in Advanced Cancer
Rudolph M. Navari
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2020)
New role of the antidepressant imipramine as a Fascin1 inhibitor in colorectal cancer cells
Begona Alburquerque-Gonzalez et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processes
Nicole Kiweler et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Fluoxetine as an antidepressant medicine improves the effects of ionizing radiation for the treatment of glioma
Seyed Jalal Hosseinimehr et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2020)
Induction of apoptosis through extrinsic/intrinsic pathways and suppression of ERK/NF-κB signalling participate in anti-glioblastoma of imipramine
Fei-Ting Hsu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
OSgbm: An Online Consensus Survival Analysis Web Server for Glioblastoma
Huan Dong et al.
FRONTIERS IN GENETICS (2020)
The dopamine receptor antagonist trifluoperazine prevents phenotype conversion and improves survival in mouse models of glioblastoma
Kruttika Bhat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma
Jack Meng-Fen Su et al.
PEDIATRIC BLOOD & CANCER (2020)
Beneficial effect of fluoxetine on anti-tumor progression on hepatocellular carcinoma and non-small cell lung cancer bearing animal model
Li-Cho Hsu et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Valproic Acid Enhanced Apoptosis by Promoting Autophagy Via Akt/mTOR Signaling in Glioma
Wei Han et al.
CELL TRANSPLANTATION (2020)
Glioblastoma Stem-Like Cells, Metabolic Strategy to Kill a Challenging Target
Delphine Garnier et al.
FRONTIERS IN ONCOLOGY (2019)
Olanzapine induced autophagy through suppression of NF-κB activation in human glioma cells
Ying Zhu et al.
CNS NEUROSCIENCE & THERAPEUTICS (2019)
ID1 Is Critical for Tumorigenesis and Regulates Chemoresistance in Glioblastoma
Rohit Sachdeva et al.
CANCER RESEARCH (2019)
Electrical and synaptic integration of glioma into neural circuits
Humsa S. Venkatesh et al.
NATURE (2019)
Glutamatergic synaptic input to glioma cells drives brain tumour progression
Varun Venkataramani et al.
NATURE (2019)
Fluoxetine Enhances Anti-tumor Activity of Paclitaxel in Gastric Adenocarcinoma Cells by Triggering Apoptosis and Necroptosis
Tin Myo Khing et al.
ANTICANCER RESEARCH (2019)
Surprising Anticancer Activities of Psychiatric Medications: Old Drugs Offer New Hope for Patients With Brain Cancer
Chuanjun Zhuo et al.
FRONTIERS IN PHARMACOLOGY (2019)
Repositioning of the antipsychotic trifluoperazine: Synthesis, biological evaluation and in silico study of trifluoperazine analogs as anti-glioblastoma agents
Seokmin Kang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Calmodulin antagonist enhances DR5-mediated apoptotic signaling in TRA-8 resistant triple negative breast cancer cells
Romone M. Fancy et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
EGFRvIII-Stat5 Signaling Enhances Glioblastoma Cell Migration and Survival
Alison Roos et al.
MOLECULAR CANCER RESEARCH (2018)
Drug Repositioning in Glioblastoma: A Pathway Perspective
Sze Kiat Tan et al.
FRONTIERS IN PHARMACOLOGY (2018)
Trends and patterns of incidence of diffuse glioma in adults in the United States, 1973-2014
Kai Li et al.
CANCER MEDICINE (2018)
The antidepressant fluoxetine induces necrosis by energy depletion and mitochondrial calcium overload
Emilie Charles et al.
ONCOTARGET (2017)
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes
Elisabetta Maffioletti et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2017)
Treatment of Glioblastoma in Older Adults
Kelly Braun et al.
CURRENT ONCOLOGY REPORTS (2017)
Assessment of citalopram and escitalopram on neuroblastoma cell lines: Cell toxicity and gene modulation
Laurent Sakka et al.
ONCOTARGET (2017)
Repositioning chlorpromazine for treating chemoresistant glioma through the inhibition of cytochrome c oxidase bearing the COX4-1 regulatory subunit
Claudia R. Oliva et al.
ONCOTARGET (2017)
Reversing glioma malignancy: a new look at the role of antidepressant drugs as adjuvant therapy for glioblastoma multiforme
Anna M. Bielecka-Wajdman et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling
Sheng Han et al.
BRITISH JOURNAL OF CANCER (2017)
Inhibition of the NMDA and AMPA receptor channels by antidepressants and antipsychotics
Oleg I. Barygin et al.
BRAIN RESEARCH (2017)
The antipsychotic drug pimozide inhibits cell growth in prostate cancer through suppression of STAT3 activation
Wei Zhou et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4
Xiaopeng Lan et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
USP1 targeting impedes GBM growth by inhibiting stem cell maintenance and radioresistance
Jin-Ku Lee et al.
NEURO-ONCOLOGY (2016)
CRM1/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathways
Xuejiao Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Trifluoperazine A Sprightly Old Drugin
Robert H. Howland
JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES (2016)
Fluoxetine synergizes with temozolomide to induce the CHOP-dependent endoplasmic reticulum stress-related apoptosis pathway in glioma cells
Jian Ma et al.
ONCOLOGY REPORTS (2016)
Fluvoxamine, an anti-depressant, inhibits human glioblastoma invasion by disrupting actin polymerization
Keiichiro Hayashi et al.
SCIENTIFIC REPORTS (2016)
Comparison of the Anti-tumor Effects of Selective Serotonin Reuptake Inhibitors as Well as Serotonin and Norepinephrine Reuptake Inhibitors in Human Hepatocellular Carcinoma Cells
Jun Kuwahara et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2015)
Lithium chloride induces mesenchymal-to-epithelial reverting transition in primary colon cancer cell cultures
Valeria Costabile et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
EAG2 potassium channel with evolutionarily conserved function as a brain tumor target
Xi Huang et al.
NATURE NEUROSCIENCE (2015)
Monoamine NMDA receptor channel blockers inhibit and potentiate native and recombinant proton-gated ion channels
Tatiana B. Tikhonova et al.
NEUROPHARMACOLOGY (2015)
Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide's antiproliferative effect
Georg Karpel-Massler et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Novel Drug Candidates for the Treatment of Metastatic Colorectal Cancer through Global Inverse Gene-Expression Profiling
Vera van Noort et al.
CANCER RESEARCH (2014)
CUSP9*treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide
Richard E. Kast et al.
ONCOTARGET (2014)
The antipsychotic agent chlorpromazine induces autophagic cell death by inhibiting the Akt/mTOR pathway in human U-87MG glioma cells
Soon Young Shin et al.
CARCINOGENESIS (2013)
Antidepressant drugs as a complementary therapeutic strategy in cancer
Anna M. Bielecka et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2013)
mTORC2 controls actin polymerization required for consolidation of long-term memory
Wei Huang et al.
NATURE NEUROSCIENCE (2013)
Comparative drug pair screening across multiple glioblastoma cell lines reveals novel drug-drug interactions
Linnea Schmidt et al.
NEURO-ONCOLOGY (2013)
A conceptually new treatment approach for relapsed glioblastoma: Coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care.
Richard E. Kast et al.
ONCOTARGET (2013)
Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results
Sharon Berendsen et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Valproic acid sensitizes human glioma cells for temozolomide and γ-radiation
Krista A. Van Nifterik et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
VPA inhibits breast cancer cell migration by specifically targeting HDAC2 and down-regulating Survivin
Lei Zhang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
Valproic Acid Inhibits Angiogenesis In Vitro and Glioma Angiogenesis In Vivo in the Brain
Satoru Osuka et al.
NEUROLOGIA MEDICO-CHIRURGICA (2012)
The tricyclic antidepressant imipramine induces autophagic cell death in U-87MG glioma cells
Seung-Hyun Jeon et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
The role of Eag and HERG channels in cell proliferation and apoptotic cell death in SK-OV-3 ovarian cancer cell line
Viren Asher et al.
CANCER CELL INTERNATIONAL (2011)
Glutamate release by primary brain tumors induces epileptic activity
Susan C. Buckingham et al.
NATURE MEDICINE (2011)
Glioblastoma chemotherapy adjunct via potent serotonin receptor-7 inhibition using currently marketed high-affinity antipsychotic medicines
R. E. Kast
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Chlorpromazine activates p21Waf1/Cip1 gene transcription via early growth response-1 (Egr-1) in C6 glioma cells
Soon Young Shin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2010)
Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines
Jun Fu et al.
NEURO-ONCOLOGY (2010)
Glycogen synthase kinase-3 inhibitors augment TRAIL-induced apoptotic death in human hepatoma cells
Eleonore Beurel et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Potential Inhibition of PDK1/Akt Signaling by Phenothiazines Suppresses Cancer Cell Proliferation and Survival
Jang Hyun Choi et al.
RECENT ADVANCES IN CLINICAL ONCOLOGY (2008)
Valproic acid was well tolerated in heavily pretreated pediatric patients with high-grade glioma
Johannes E. A. Wolff et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3
Michal O. Nowicki et al.
NEURO-ONCOLOGY (2008)
The novel combination of chlorpromazine and pentamidine exerts synergistic antiproliferative effects through dual mitotic action
Margaret S. Lee et al.
CANCER RESEARCH (2007)
Trifluoperazine stimulates ionizing radiation induced cell killing through inhibition of DNA repair
Sudeshna Gangopadhyay et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2007)
Focal adhesion kinase controls actin assembly via a FERM-mediated interaction with the Arp2/3 complex
Bryan Serrels et al.
NATURE CELL BIOLOGY (2007)
Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes - Phenothiazines and leukemia
Z Zhelev et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
Mechanism of block of hEag1 K+ channels by imipramine and astemizole
RE García-Ferreiro et al.
JOURNAL OF GENERAL PHYSIOLOGY (2004)
Antiproliferative action of valproate is associated with aberrant expression and nuclear translocation of cyclin D3 during the C6 glioma G1 phase
CL Bacon et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Fluoxetine - A review of its therapeutic potential in the treatment of depression associated with physical illness
SM Cheer et al.
DRUGS (2001)
Share Paper
